Elevated fasting plasma ghrelin in Prader-Willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 4, 2004, Pages 1718-1726

  Goldstone, Anthony P ^a,b,d   Thomas, E Louise ^b   Brynes, Audrey E ^b   Castroman, Gabriela ^a   Edwards, Ray ^a   Ghatei, Mohammad A ^b   Frost, Gary ^b   Holland, Anthony J ^c   Grossman, Ashley B ^a   Korbonits, Márta ^a   Bloom, Stephen R ^b   Bell, Jimmy D ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; SOMATOMEDIN;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; LIPID STORAGE; MALE; MEASUREMENT; OBESITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; VISCERA;

ADIPOSE TISSUE; ADULT; CASE-CONTROL STUDIES; FASTING; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDE HORMONES; PRADER-WILLI SYNDROME; PROTEIN PRECURSORS; REGRESSION ANALYSIS; VISCERA;

EID: 11144356346     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031118     Document Type: Article

References (65)

1. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg F 1993 Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 91:398-402
2. Goldstone AP 2004 Prader-Willi syndrome: advances in its genetics, pathophysiology and treatment. Trends Endocrinol Metab 15:12-20
3. Nicholls RD, Saltoh S, Horsthemke B 1998 Imprinting in Prader-Willi and Angelman syndromes. Trends Genet 14:194-200
4. Goldstone AP, Brynes AE, Thomas EL, Bell JD, Frost G, Holland A, Ghatei MA, Bloom SR 2002 Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. Am J Clin Nutr 75:468-475
5. Goldstone AP, Thomas EL, Brynes AE, Bell JD, Frost G, Saeed N, Hajnal JV, Howard JK, Holland A, Bloom SR 2001 Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab 86:4330-4338
6. Goldstone AP, Unmehopa UA, Thomas EL, Brynes AE, Bell JD, Frost G, Ghatei MA, Holland A, Bloom SR, Swaab DF 2003 Hypothalamic neuropeptides and regulation of fat mass in Prader-Willi syndrome. In: Eiholzer U, l'Allemand D, Zipf W, eds. Prader-Willi syndrome as a model for obesity. Basel, Switzerland: Karger; 31-43
7. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Van der Ploeg LH 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977
8. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
9. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS 2001 A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719
10. Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG, Kangawa K, Grossman AB 2001 The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 86:881-887
11. Lu S, Guan JL, Wang QP, Uehara K, Yamada S, Goto N, Date Y, Nakazato M, Kojima M, Kangawa K, Shioda S 2001 Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci Lett 321: 157-160
12. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL 2003 The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649-661
13. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S 2001 A role for ghrelin in the central regulation of feeding. Nature 409:194-198
14. Tschop M, Smiley DL, Heiman ML 2000 Ghrelin induces adiposity in rodents. Nature 407:908-913
15. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR 2001 Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992-5995
16. Cummings DE, Clement K, Pumell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS 2002 Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 8:643-644
17. Delparigi A, Tschop M, Heiman ML, Salbe AD, Vozarova B, Sell SM, Bunt JC, Tataranni PA 2002 High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. J Clin Endocrinol Metab 87:5461-5464
18. Haqq AM, Farooqi IS, O'Rahilly S, Stadler DD, Rosenfeld RG, Pratt KL, LaFranchi SH, Purnell JQ 2003 Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab 88:174-178
19. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML 2001 Circulating ghrelin levels are decreased in human obesity. Diabetes 50: 707-709
20. Janssen JA, van der Toorn FM, Hofland LJ, van Koetsveld P, Broglio F, Ghigo E, Lamberts SW, Jan vdL 2001 Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur J Endocrinol 145:711-716
21. Bellone S, Rapa A, Vivenza D, Castellino N, Petri A, Bellone J, Me E, Broglio F, Prodam F, Ghigo E, Bona G 2002 Circulating ghrelin levels as function of gender, pubertal status and adiposity in childhood. J Endocrinol Invest 25: RC13-RC15
22. Haqq AM, Stadler DD, Jackson RH, Rosenfeld RG, Pumell JQ, LaFranchi SH 2003 Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab 88:2206-2212
23. Mohlig M, Spranger J, Otto B, Ristow M, Tschop M, Pfeiffer AF 2002 Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest 25:RC36-RC38
24. Rigamonti AE, Pincelli AI, Corra B, Viarengo R, Bonomo SM, Galimberti D, Scacchi M, Scarpini E, Cavagnini F, Muller EE 2002 Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. J Endocrinol 175:R1-R5
25. Flanagan DE, Evans ML, Monsod TP, Rife F, Heptulla RA, Tamborlane WV, Sherwin RS 2003 The influence of insulin on circulating ghrelin. Am J Physiol 284:E313-E316
26. Ikezaki A, Hosoda H, Ito K, Iwama S, Miura N, Matsuoka H, Kondo C, Kojima M, Kangawa K, Sugihara S 2002 Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 51:3408-3411
27. McCowen KC, Maykel JA, Bistrian BR, Ling PR 2002 Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents. J Endocrinol 175:R7-R11
28. Pagotto U, Gambineri A, Vicennati V, Heiman ML, Tschop M, Pasquali R 2002 Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels. J Clin Endocrinol Metab 87:5625-5629
29. Kieffer TJ, Habener JF 1999 The glucagon-like peptides. Endocr Rev 20:876-913
30. Thomas EL, Saeed N, Hajnal JV, Brynes A, Goldstone AP, Frost G, Bell JD 1998 Magnetic resonance imaging of total body fat. J Appl Physiol 85:1778-1785
31. Kreymann B, Williams G, Ghatei MA, Bloom SR 1987 Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2:1300-1304
32. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
33. Caixas A, Bashore C, Nash W, Pi-Sunyer F, Laferrere B 2002 Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab 87:1902-1906
34. Höybye C, Barkeling B, Espelund U, Petersson M, Thoren M 2003 Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment. Growth Horm IGF Res 13:322-327
35. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M 2002 The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:2988-2991
36. Lee HM, Wang G, Englander EW, Kojima M, Greeley GHJ 2002 Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 143:185-190
37. Zipf WB, O'Dorisio TM, Cataland S, Sotos J 1981 Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome. J Clin Endocrinol Metab 52:1264-1266
38. DiMario FJJ, Dunham B, Burleson JA, Moskovitz J, Cassidy SB 1994 An evaluation of autonomic nervous system function in patients with Prader-Willi syndrome. Pediatrics 93:76-81
39. DiMario FJJ, Bauer L, Volpe J, Cassidy SB 1996 Respiratory sinus arrhythmia in patients with Prader-Willi syndrome. J Child Neurol 11:121-125
40. Kreier F, Fliers E, Voshol PJ, Van Eden CG, Havekes LM, Kalsbeek A, Van Heijningen CL, Sluiter AA, Mettenleiter TC, Romijn JA, Sauerwein HP, Buijs RM 2002 Selective parasympathetic innervation of subcutaneous and intra-abdominal fat: functional implications. J Clin Invest 110:1243-1250
41. Rocca AS, Brubaker PL 1999 Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 140:1687-1694
42. Zhang X, Fogel R, Renehan WE 1999 Stimulation of the paraventricular nucleus modulates the activity of gut-sensitive neurons in the vagal complex. Am J Physiol 277:G79-G90
43. Novin D, Rogers RC, Hermann G 1981 Visceral afferent and efferent connections in the brain. Diabetologia 20(Suppl):331-336
44. Lee CH, Jung HS, Lee TY, Lee SR, Yuk SW, Lee KG, Lee BH 2002 Studies of the central neural pathways to the stomach and Zusanli (ST36). Am J Chin Med 29:211-220
45. Rinaman L 1998 Oxytocinergic inputs to the nucleus of the solitary tract and dorsal motor nucleus of the vagus in neonatal rats. J Comp Neurol 399:101-109
46. Buijs RM, De Vries GJ, van Leeuwen FW, Swaab DF 1983 Vasopressin and oxytocin: distribution and putative functions in the brain. Prog Brain Res 60:115-122
47. Dreifuss JJ, Raggenbass M, Charpak S, Dubois-Dauphin M, Tribollet E 1988 A role of central oxytocin in autonomic functions: its action in the motor nucleus of the vagus nerve. Brain Res Bull 20:765-770
48. Swaab DF, Purba JS, Hofman MA 1995 Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab 80:573-579
49. Muscatelli F, Abrous DN, Massacrier A, Boccaccio I, Le Moal M, Cau P, Cremer H 2000 Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum Mol Genet 9:3101-3110
50. Rittmaster RS, Loriaux DL, Merriam GR 1987 Effect of continuous somatostatin and growth hormone-releasing hormone (GHRH) infusions on the subsequent growth hormone (GH) response to GHRH. Evidence for somatotroph desensitization independent of GH pool depletion. Neuroendocrinology 45:118-122
51. Vance ML, Kaiser DL, Rivier J, Vale W, Thorner MO 1986 Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH. J Clin Endocrinol Metab 62:591-594
52. Glavaski-Joksimovic A, Jeftinija K, Scanes CG, Anderson LL, Jeftinija S 2003 Stimulatory effect of ghrelin on isolated porcine somatotropes. Neuroendocrinology 77:367-379
53. Thompson NM, Davies JS, Mode A, Houston PA, Wells T 2003 Pattern-dependent suppression of growth hormone (GH) pulsatility by ghrelin and GH-releasing peptide-6 in moderately GH-deficient rats. Endocrinology 144: 4859-4867
54. Tannenbaum GS, Lapointe M, Beaudet A, Howard AD 1998 Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology 139:4420-4423
55. Tannenbaum GS, Bowers CY 2001 Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin. Endocrine 14: 21-27
56. Zheng H, Bailey A, Jiang MH, Honda K, Chen HY, Trumbauer ME, Van der Ploeg LH, Schaeffer JM, Leng G, Smith RG 1997 Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons. Mol Endocrinol 11:1709-1717
57. Goldstone AP, Unmehopa UA, Swaab DF 2003 2003 Hypothalamic growth hormone-releasing hormone (GHRH) cell number is increased in human illness, but is not reduced in Prader-Willi syndrome or obesity. Clin Endocrinol (Oxf) [Erratum (2003) 59:266] 58:743-755
58. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I 2001 Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and agouti-related protein mRNA levels and body weight in rats. Diabetes 50: 2438-2443
59. Goldstone AP, Unmehopa UA, Bloom SR, Swaab DF 2002 Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects. J Clin Endocrinol Metab 87:927-937
60. Swaab DF 1997 Neurobiology and neuropathology of the human hypothalamus. In: Bloom FE, Hökfelt T, eds. Handbook of chemical neuroanatomy, vol 13, part I. Amsterdam: Elsevier; 39-137
61. Ravid R, Van Zwleten EJ, Swaab DF 1992 Brain banking and the human hypothalamus: factors to match for, pitfalls and potentials. Prog Brain Res 93:83-95
62. Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M 2002 The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123:1120-1128
63. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS 1999 Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20:68-100
64. Weikel JC, Wichniak A, Ising M, Brunner H, Friess E, Held K, Mathias S, Schmid DA, Uhr M, Steiger A 2002 Ghrelin promotes slow-wave sleep in man. Am J Physiol 284:E407-E415
65. Haqq AM, Stadler DD, Rosenfeld RG, Pratt KL, Weigle DS, Frayo RS, LaFranchi SH, Cummings DE, Purnell JQ 2003 Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome. J Clin Endocrinol Metab 88:3573-3576